Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-03-17$1.78/sh−6,999$12,479→ 292,816 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.